These studies, namely PanScan I12, PanScan II13, PanScan III14,15, and PanC416, have led to the identification of 13 genomic loci carrying 17 independent pancreatic cancer risk signals on chromosomes 1q32.1 (two independent signals in NR5A2), 2p14 (ETAA1), 3q28 (TP63), 5p15.33 (three independent risk loci in the CLPTM1L-TERT gene region), 7p14.1 (SUGCT), 7q23.2 (LINC-PINT), 8q24.1 (two independent risk loci in the MYC-PVT1 gene region), 9q34.2 (ABO), 13q12.2 (PDX1), 13q22.1 (non-genic), 16q23.1 (BCAR1), 17q24.3 (LINC00673), and 22q12.1 (ZNRF3)12–16. Here, TP63 is linked to pancreatic neoplasm.